| Entry |
|
|---|
| Name |
Benzylthiouracil;
Basdene (TN) |
|---|
| Formula |
C11H10N2OS
|
|---|
| Exact mass |
218.0514
|
|---|
| Mol weight |
218.2749
|
|---|
| Structure |
|
|---|
| Class |
Hormonal agent
DG01934 Antithyroid agent
|
|---|
| Remark |
|
|---|
| Efficacy |
Antithyroid, Thyroid hormone synthesis inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H03 THYROID THERAPY
H03B ANTITHYROID PREPARATIONS
H03BA Thiouracils
H03BA03 Benzylthiouracil
D07519 Benzylthiouracil
Drug groups [BR:br08330]
Hormonal agent
DG01934 Antithyroid agent
D07519 Benzylthiouracil
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Peroxidase
TPO
D07519 Benzylthiouracil
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 15
1 C5x C 28.0700 -17.3600
2 C1z C 27.3700 -18.5500
3 C2y C 28.0000 -19.8100
4 N2x N 29.4000 -19.8100
5 C2x C 30.1700 -18.6200
6 N2x N 29.4700 -17.3600
7 O5x O 27.3700 -16.1000
8 C1b C 26.1800 -17.8500
9 C1y C 24.9900 -18.5500
10 C2x C 23.8000 -17.8500
11 C2x C 22.5400 -18.5500
12 C2x C 22.5400 -19.9500
13 C2x C 23.8000 -20.6500
14 C1x C 24.9900 -19.9500
15 S2x S 26.6700 -19.8100
BOND 17
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 2
8 8 2 1
9 8 9 1
10 9 10 1
11 10 11 2
12 11 12 1
13 12 13 2
14 13 14 1
15 9 14 1
16 15 3 1
17 2 15 1
|
|---|
